News and Announcements
Announcing the Launch of Empower Group O Care
The Red Cross is thrilled to introduce Empower Group O Care, an innovative initiative set to tackle one of the most pressing issues in transfusion medicine today – ensuring a sustainable and reliable supply of O negative Red Blood Cells. As an industry leader with extensive expertise in transfusion medicine, we are championing responsible stewardship practices of both O negative and O positive blood through ongoing educational events and supportive hospital resources, including toolkits and reference documents.
Empower Group O Care underscores our collective obligation to act now to ensure life-saving blood products are consistently available to those who need them most. Join us as we work together to better steward this vital blood supply and support improved patient outcomes.
Events
Adverse Reaction to Transfusion: Laboratory Investigation (Part 1)
Date: April 21
Adverse Reaction to Transfusion: Laboratory Investigation (Part 2)
Date: April 22
Foundations of IgA Deficiency
Date: April 23
Laboratory Services Case Studies: IRL Case - Specialized Testing Case
- HLA Case
Date: April 24
Media Messaging Toolkit
The American Red Cross welcomes participation of our hospital partners in the recruitment of blood donors, especially in times of critical shortages. For your convenience, we have made available prepared messaging and graphics that can be used to promote the need for blood donations.
Blood Supply Messaging Resource Guide
Inform and engage your staff and community about the need for refueling the blood supply through blood and platelet donations.
Blood Saves Lives: Helping People with Sickle Cell Disease
Inform and engage your staff and community about the need for diverse donors to help patients battling sickle cell disease.
PLUS Online
An Educational Resource for Transfusion Medicine
Hemoglobin-Based Oxygen Carriers – Are We There Yet?
Jahr and colleagues1 recently summarized the history of hemoglobin-based oxygen carriers (HBOCs) to the present day, comparing biochemical and biophysical properties, safety concerns, and therapeutic potential as alternatives to packed red blood cell (PRBC) transfusions. HBOCs have been investigated for nearly a century as synthetic oxygen carriers in situations including the unavailability of rare antigen-negative […]
Continue ReadingProphylactic red blood cell matching in patients with sickle cell disease (SCD) and transfusion-dependent thalassemia (TDT)
The January 2025 issue of the British Journal of Haematology (BJHAEM) published an updated evidence-based guideline for red blood cell antigen matching in patients with hemoglobinopathies.1 Alloimmunization to red blood cell antigens has been linked to patient morbidity and mortality in patients with sickle cell disease (SCD) and transfusion-dependent thalassemia (TDT). The practice of transfusing […]
Continue Reading